arbekacin and Co-infection

arbekacin has been researched along with Co-infection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hamada, Y; Koyama, I; Kuroyama, M; Sunakawa, K; Tamura, K; Yago, K	1

Other Studies

1 other study(ies) available for arbekacin and Co-infection

Article	Year
Clinical efficacy of arbekacin for Gram-negative bacteria. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coinfection; Dibekacin; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections	2011

Article

Year

Clinical efficacy of arbekacin for Gram-negative bacteria.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coinfection; Dibekacin; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Staphylococcal Infections

2011